These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10977017)

  • 1. Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals.
    Reunanen A; Kangas T; Martikainen J; Klaukka T
    Diabetes Care; 2000 Sep; 23(9):1265-71. PubMed ID: 10977017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and costs of health care of diabetic patients in Finland.
    Kangas T; Aro S; Koivisto VA; Salinto M; Laakso M; Reunanen A
    Diabetes Care; 1996 May; 19(5):494-7. PubMed ID: 8732715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.
    Rathmann W; Haastert B; Icks A; Giani G
    Diabetes Care; 2007 Apr; 30(4):848-53. PubMed ID: 17392545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes.
    Eby EL; Van Brunt K; Brusko C; Curtis B; Lage MJ
    Clin Interv Aging; 2015; 10():991-1001. PubMed ID: 26124652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of known diabetes mellitus in Spain].
    Hart WM; Espinosa C; Rovira J
    Med Clin (Barc); 1997 Sep; 109(8):289-93. PubMed ID: 9379750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study.
    Evans JM; MacDonald TM; Leese GP; Ruta DA; Morris AD
    Diabetes Care; 2000 Jun; 23(6):770-4. PubMed ID: 10840994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.
    Demurtas J; Alba N; Rigon G; Nesoti MV; Bovo C; Vaona A
    Prim Care Diabetes; 2017 Dec; 11(6):570-576. PubMed ID: 28663023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost of diabetes mellitus in Spain].
    González P; Faure E; Del Castillo A;
    Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
    [No Abstract]   [Full Text] [Related]  

  • 13. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess mortality in Finnish diabetic subjects due to alcohol, accidents and suicide: a nationwide study.
    Niskanen L; Partonen T; Auvinen A; Haukka J
    Eur J Endocrinol; 2018 Oct; 179(5):299-306. PubMed ID: 30320503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral diabetes medications other than dipeptidyl peptidase 4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study.
    Varpuluoma O; Försti AK; Jokelainen J; Turpeinen M; Timonen M; Tasanen K; Huilaja L
    J Am Acad Dermatol; 2018 Dec; 79(6):1034-1038.e5. PubMed ID: 29803903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does increased adherence to medications change health care financial burdens for adults with diabetes?
    Miller GE; Sarpong EM; Hill SC
    J Diabetes; 2015 Nov; 7(6):872-80. PubMed ID: 25817601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
    Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
    Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes.
    Rettig SM; Wood Y; Hirsch JD
    J Am Pharm Assoc (2003); 2013; 53(4):427-31. PubMed ID: 23892818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study.
    Narbro K; Agren G; Jonsson E; Näslund I; Sjöström L; Peltonen M;
    Arch Intern Med; 2002 Oct; 162(18):2061-9. PubMed ID: 12374514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.